A new venture firm, OMX Ventures, is out of stealth with its first $150 million fund, the backing of the billionaire Merieux family, and 15 investments in bio-engineering startups.
As a growing class of care robots claim to provide the elderly with the benefits of human connection through technology, what risks and opportunities must designers consider?
Prince Charles announced a new business pledge for nature last week. However, the inclusion of BP has been slammed for allowing the oil giant to continue greenwashing environmental pledges, as they refuse to support the Mauritius oil spill inquiry which centers around BP's controversial ship fuel.
Since President Trump entered office, U. S. imports from China have fallen 10 times more than U. S. exports, lessening the U. S. trade deficit with China.
With reports that Covid-19 vaccines are being stolen and sold on the black market, Tom Knight, CEO of Atlanta-based inventory visibility and analytics firm Invistics, says he saw this coming back in April 2020.
As they look to a post-Covid-19 environment, business leaders are making their supply chains more flexible and resilient—both to respond to this pandemic and better prepare for future disruptions.
Surging demand for electric vehicles and solar energy is proving to be a double boon for Malaysia’s Greatech Technology. The company’s shares jumped 330% in the past year, propelling its cofounder, Tan Eng Kee, into the billionaires club.
BP issued a statement on Tuesday, admitting for the first time that it supplied the oil used in the Wakashio. However, it denied responsibility for the Mauritius oil spill. The type of fuel on board was an experimental ship fuel found to cause engine problems around the world.
Domestic deindustrialization threatens the nation's economic and military security, warns a 180-page report that offers a sector-by-sector glimpse of just how severe the nation’s industrial decline has been.
The goal of Operation Warp Speed was to produce and deliver 300 million doses of safe and effective vaccines with the initial doses available by January 2021. The program shortfall needs to be a call for leaders to rethink current assumptions and act to design a vaccination supply chain.